Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Amicus Therapeuticsamicusrx.com · Low evidenceAmicus Therapeutics is a biotechnology company and wholly owned subsidiary of BioMarin Pharmaceutical that focuses on developing therapies for rare diseases. The company is guided by people living with genetically defined conditions globally.
Parse Score